Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Indian Journal of Pediatrics
Erschienen in: Indian Journal of Pediatrics 10/2016

18.12.2015 | Review Article

Approach to the Diagnosis of Overgrowth Syndromes

verfasst von: Mohnish Suri

Erschienen in: Indian Journal of Pediatrics | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

Overgrowth syndromes comprise a group of disorders associated with excessive growth and other features such as facial dysmorphism, developmental delay or intellectual disability, congenital anomalies, neurological problems and an increased risk of neoplasia. Recent advances in understanding the genetic basis of overgrowth syndromes has resulted in a move away from clinical classification to molecular classification of overgrowth syndromes. This review provides a structured clinical approach to patients with this group of disorders and includes most of the currently known overgrowth syndromes.
Literatur
1.
Lapunzina P Risk of tumorigenesis in overgrowth syndromes: a comprehensive review. Am J Med Genet C Semin Med Genet. 2005;137C:53–71.CrossRefPubMed
2.
Hennekam RCM, Allanson JE, Krantz ID, editors. Gorlin’s syndromes of the head and neck. 5th ed. New York: Oxford University Press; 2010. p. 471–516.
3.
Tatton-Brown K, Weksberg R. Molecular mechanisms of childhood overgrowth. Am J Med Genet Part C Semin Med Genet. 2013;163C:71–5.CrossRefPubMed
4.
5.
Tatton-Brown N, Murray A, Hanks S, et al. Weaver syndrome and EZH2 mutations: clarifying the clinical phenotype. Am J Med Genet A. 2013;161A:2972–80.CrossRefPubMed
6.
Shaw AC, van Balkom ID, Bauer M, et al. Phenotype and natural history in Marshall-Smith syndrome. Am J Med Genet A. 2010;152A:2714–26.CrossRefPubMed
7.
Malan V, Rajan D, Thomas S, et al. Distinct effects of allelic NFIX mutations on nonsense-mediated mRNA decay engender either a Sotos-like or a Marshall-Smith syndrome. Am J Hum Genet. 2010;87:189–98.CrossRefPubMedPubMedCentral
8.
Klaassens M, Morrogh D, Rosser EM, et al. Malan syndrome: sotos-like overgrowth with de novo NFIX sequence variants and deletions in six new patients and a review of the literature. Eur J Hum Genet. 2015;23:610–5.CrossRefPubMed
9.
10.
Choufani S, Shuman C, Weksberg R. Molecular findings in Beckwith-Wiedemann syndrome. Am J Med Genet Part C Semin Med Genet. 2013;163C:131–40.CrossRefPubMed
11.
Brioude F, Lacoste A, Netchine I, et al. Beckwith-Wiedemann syndrome: growth pattern and tumor risk according to molecular mechanism, and guidelines for tumor surveillance. Horm Res Paediatr. 2013;80:457–65.CrossRefPubMed
12.
Cottereau E, Mortemousque M, Moizard M-P, et al. Phenotypic spectrum of Simpson-Golabi-Behmel syndrome in a series of 42 cases with a mutation in GPC3 and review of the literature. Am J Med Genet Part C Semin Med Genet. 2013;163C:92–105.CrossRefPubMed
13.
Alessandri JL, Cuillier F, Ramful D, et al. Perlman syndrome: report, prenatal findings and review. Am J Med Genet A. 2008;146A:2532–7.CrossRefPubMed
14.
Morris M, Astuti D, Maher ER. Perlman syndrome: overgrowth, Wilms tumor predisposition and DIS3L2. Am J Med Genet Part C Semin Med Genet. 2013;163C:106–13.CrossRefPubMed
15.
Douglas J, Cilliers D, Coleman K, et al. Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth. Nat Genet. 2007;39:963–5.CrossRefPubMed
16.
Mensink KA, Ketterling RP, Flynn HC, et al. Connective tissue dysplasia in five new patients with NF1 microdeletions: further expansion of phenotype and review of the literature. J Med Genet. 2006;43:e8.CrossRefPubMedPubMedCentral
17.
18.
Tatton-Brown K, Seal S, Ruark E, et al. Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability. Nat Genet. 2014;46:385–8.CrossRefPubMedPubMedCentral
19.
20.
Giunta C, Randolph A, Al-Gazali LI, Brunner HG, Kraenzlin ME, Steinmann B. Nevo syndrome is allelic to the kyphoscoliotic type of the Ehlers-Danlos syndrome (EDS VIA). Am J Med Genet A. 2005;133A:158–64.CrossRefPubMed
21.
Blumenthal GM, Dennis PA. PTEN hamartoma tumor syndromes. Eur J Hum Genet. 2008;16:1289–300.CrossRefPubMed
22.
Mester J, Eng C. When overgrowth bumps into cancer: the PTEN-opathies. Am J Med Genet Part C Semin Med Genet. 2013;163C:114–21.CrossRefPubMed
23.
Smpokou P, Fox VL, Tan WH. PTEN hamartoma tumour syndrome: early tumour development in children. Arch Dis Child. 2015;100:34–7.CrossRefPubMed
24.
Terracciano A, Chiurazzi P, Neri G. Fragile X syndrome. Am J Med Genet C Semin Med Genet. 2005;137C:32–7.CrossRefPubMed
25.
Clayton-Smith J, Kerr B, Brunner H, et al. Macrocephaly with cutis marmorata, haemangioma and syndactyly–a distinctive overgrowth syndrome. Clin Dysmorphol. 1997;6:291–302.CrossRefPubMed
26.
Mirzaa GM, Conway RL, Gripp KW, et al. Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis. Am J Med Genet A. 2012;158A:269–91.CrossRefPubMed
27.
Rivière JB, Mirzaa GM, O’Roak BJ, et al. De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat Genet. 2012;44:934–40.CrossRefPubMedPubMedCentral
28.
Mirzaa GM, Rivière JB, Dobyns WB. Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP. Am J Med Genet C Semin Med Genet. 2013;163C:122–30.CrossRefPubMed
29.
Sapp JC, Turner JT, van de Kamp JM, van Dijk FS, Lowry RB, Biesecker LG. Newly delineated syndrome of congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE syndrome) in seven patients. Am J Med Genet A. 2007;143A:2944–58.CrossRefPubMed
30.
31.
Keppler-Noreuil KM, Sapp JC, Lindhurst MJ, et al. Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum. Am J Med Genet A. 2014;164A:1713–33.CrossRefPubMed
32.
Lindhurst MJ, Sapp JC, Teer JK, et al. A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med. 2011;365:611–9.CrossRefPubMedPubMedCentral
33.
Cohen MM Jr. Proteus syndrome review: molecular, clinical, and pathologic features. Clin Genet. 2014;85:111–9.
34.
Hoyme HE, Seaver LH, Jones KL, Procopio F, Crooks W, Feingold M. Isolated hemihyperplasia (hemihypertrophy): report of a prospective multicenter study of the incidence of neoplasia and review. Am J Med Genet. 1998;79:274–8.CrossRefPubMed
35.
Dempsey-Robertson M, Wilkes D, Stall A, Bush P. Incidence of abdominal tumors in syndromic and idiopathic hemihypertrophy/isolated hemihyperplasia. J Pediatr Orthop. 2012;32:322–6.CrossRefPubMed
36.
37.
Wilkens A, Liu H, Park K, et al. Novel clinical manifestations in Pallister-Killian syndrome: comprehensive evaluation of 59 affected individuals and review of previously reported cases. Am J Med Genet A. 2012;158A:3002–17.CrossRefPubMed
38.
Izumi K, Krantz ID. Pallister-Killian syndrome. Am J Med Genet C Semin Med Genet. 2014;166C:406–13.CrossRefPubMed
39.
Mauceri L, Sorge G, Incorpora G, Pavone L. Pallister-Killian syndrome: case report with pineal tumor. Am J Med Genet. 2000;95:75–8.CrossRefPubMed
40.
Tatton-Brown K, Pilz DT, Orstavik KH, et al. 15q overgrowth syndrome: a newly recognized phenotype associated with overgrowth, learning difficulties, characteristic facial appearance, renal anomalies and increased dosage of distal chromosome 15q. Am J Med Genet A. 2009;149A:147–54.CrossRefPubMed
41.
Phelan K, McDermid HE. The 22q13.3 deletion syndrome (Phelan-McDermid syndrome). Mol Syndromol. 2012;2:186–201.PubMed
42.
Derry C, Temple IK, Venkat-Raman K. A probable case of familial Weaver syndrome associated with neoplasia. J Med Genet. 1999;36:725–78.PubMedPubMedCentral
43.
44.
45.
Maher ER. Imprinting and assisted reproductive technology. Hum Mol Genet. 2005;14 Spec No 1:R133-8.
46.
Weksberg R, Shuman C, Caluseriu O, et al. Discordant KCNQ1OT1 imprinting in sets of monozygotic twins discordant for Beckwith-Wiedemann syndrome. Hum Mol Genet. 2002;11:1317–25.CrossRefPubMed
47.
Bliek J, Alders M, Maas SM, et al. Lessons from BWS twins: complex maternal and paternal hypomethylation and a common source of haematopoietic stem cells. Eur J Hum Genet. 2009;17:1625–34.CrossRefPubMedPubMedCentral
48.
Pham T, Steele J, Stayboldt C, Chan L, Benirschke K. Placental mesenchymal dysplasia is associated with high rates of intrauterine growth restriction and fetal demise: a report of 11 new cases and a review of the literature. Am J Clin Pathol. 2006;126:67–78.CrossRefPubMed
49.
Matsuo T, Ihara K, Ochiai M, et al. Hyperinsulinemic hypoglycemia of infancy in Sotos syndrome. Am J Med Genet A. 2013;161A:34–7.CrossRefPubMed
50.
51.
Jamis-Dow CA, Turner J, Biesecker LG, Choyke PL. Radiologic manifestations of Proteus syndrome. Radiographics. 2004;24:1051–68.CrossRefPubMed
52.
Alomari AI. Characterization of a distinct syndrome that associates complex truncal overgrowth, vascular, and acral anomalies: a descriptive study of 18 cases of CLOVES syndrome. Clin Dysmorphol. 2009;18:1–7.CrossRefPubMed
53.
Alomari AI, Chaudry G, Rodesch G, et al. Complex spinal-paraspinal fast-flow lesions in CLOVES syndrome: analysis of clinical and imaging findings in 6 patients. AJNR Am J Neuroradiol. 2011;32:1812–7.CrossRefPubMed
54.
Scott RH, Douglas J, Baskcomb L, et al. Methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) robustly detects and distinguishes 11p15 abnormalities associated with overgrowth and growth retardation. J Med Genet. 2008;45:106–13.CrossRefPubMed
55.
Lam WW, Hatada I, Ohishi S, et al. Analysis of germline CDKN1C (p57KIP2) mutations in familial and sporadic Beckwith-Wiedemann syndrome (BWS) provides a novel genotype-phenotype correlation. J Med Genet. 1999;36:518–23.PubMedPubMedCentral
56.
Manasse BF, Lekgate N, Pfaffenzeller WM, de Ravel TJ. The Pallister-Killian syndrome is reliably diagnosed by FISH on buccal mucosa. Clin Dysmorphol. 2000;9:163–5.CrossRefPubMed
57.
Loveday C, Tatton-Brown K, Clarke M, et al. Mutations in the PP2A regulatory subunit B family genes PPP2R5B, PPP2R5C and PPP2R5D cause human overgrowth. Hum Mol Genet. 2015;24:4775–9.CrossRefPubMedPubMedCentral
58.
GraciaBouthelier R, Lapunzina P. Follow-up and risk of tumors in overgrowth syndromes. J Pediatr Endocrinol Metab. 2005;18:S1227–35.
59.
Partington MW, Robinson H, Laing S, Turner G. Mortality in the fragile X syndrome: preliminary data. Am J Med Genet. 1992;43:120–3.CrossRefPubMed
60.
Schultz-Pedersen S, Hasle H, Olsen JH, Friedrich U. Evidence of decreased risk of cancer in individuals with fragile X. Am J Med Genet. 2001;103:226–30.CrossRefPubMed
61.
Farach A, Farach LS, Paulino AC. Therapeutic challenges in treating patients with fragile X syndrome and neoplasia. Pediatr Blood Cancer. 2013;60:E153–6.PubMed
62.
Pasmant E, Sabbagh A, Spurlock G, et al. NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype. Hum Mutat. 2010;31:E1506–18.CrossRefPubMed
63.
Scott RH, Walker L, Olsen ØE, et al. Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice. Arch Dis Child. 2006;91:995–9.CrossRefPubMedPubMedCentral
Metadaten
Titel
Approach to the Diagnosis of Overgrowth Syndromes
verfasst von
Mohnish Suri
Publikationsdatum
18.12.2015
Verlag
Springer India
Erschienen in
Indian Journal of Pediatrics / Ausgabe 10/2016
Print ISSN: 0019-5456
Elektronische ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-015-1958-1

Weitere Artikel der Ausgabe 10/2016

Indian Journal of Pediatrics 10/2016 Zur Ausgabe

Original Article

Distribution and Trends of Human Parainfluenza Viruses in Hospitalised Children

Correspondence

Effect of Supplementation with Iron Fortified Biscuits on the Hemoglobin Status of Children in Rural Areas of Shimoga, Karnataka: Correspondence

Editorial

Editorial: New Horizons in Genetic Diagnosis in Pediatric Practice: The Excitement and Challenges!

Original Article

Introducing Donor Milk in a Neonatal Intensive Care Unit: A Developing Country’s Perspective

Review Article

Epileptic Encephalopathy in Childhood: A Stepwise Approach for Identification of Underlying Genetic Causes

Correspondence

Correlation of Bone Mineral Parameters with Anthropometric Measurements and the Effect of Glucocorticoids on Bone Mineral Parameters in Congenital Adrenal Hyperplasia: Correspondence

Neu im Fachgebiet Pädiatrie

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise